GLP-1 Research
Research confirms semaglutide can cause significant muscle loss — about 6 kg or a decade's worth of aging…
The clinical evidence on semaglutide's long-term safety is cautiously optimistic, but men need to understand the muscle mass…
Ozempic is a GLP-1 receptor agonist containing semaglutide, a molecularly engineered analog of your body's natural satiety hormone…
New research reveals that GLP-1 receptor agonists reduce cravings for food, alcohol, and nicotine by directly modulating the…
Semaglutide shows real fat-loss results in non-diabetic men, but the clinical evidence on safety, muscle loss, and long-term…
GLP-1 medications can strip away 10% or more of your muscle mass — here's what the research says…
A comprehensive, research-backed breakdown of the semaglutide dosing chart — covering the full escalation schedule, what happens at…
A 2026 study found that adults attempting to self-inject semaglutide completed only 44% of required steps correctly —…
Semaglutide, the drug behind Ozempic, has demonstrated clinically significant benefits for cardiovascular disease, liver disease, kidney protection, addiction,…
GLP-1 medications produce real weight loss, but stopping them triggers measurable regain — here's what the science says…